What's new in the couple thyroid and heart in 2008?;Quoi de neuf dans le couple thyroïde et cœur en 2008 ?

Annales d'Endocrinologie

Volumn 69, Issue SUPPL. 1, 2008, Pages

  Francois M ^a   Delemer, B ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Failing heart; Heart; MicroRNAs; Nkx2 5 gene; Thyroid

Indexed keywords

LIOTHYRONINE; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR NKX2.5;

ARTICLE; GENE MUTATION; HEART; HEART FAILURE; HUMAN; HYPOTHYROIDISM; ONTOGENY; PROTEIN SYNTHESIS; THYROID GLAND;

ANIMALS; HEART; HEART DISEASES; HUMANS; MICE; MICRORNAS; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; RECEPTORS, THYROID HORMONE; THYROID GLAND; TRIIODOTHYRONINE;

EID: 54349110033     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(08)73967-2     Document Type: Article

References (36)

1. Irvine R.W., Ramphal P.S., Hall C., and Char G. Stuma cordis in a Jamaican woman. Icvts 4 (2005) 83-84
2. Olivieri A., Stazi M.A., Mastroiacovo P., Fazzini C., Medda E., Spagnolo A., et al. A population-based study on the frequency of additional congenital malformations in infants with congenital malformations in infants with congenital hypothyroidism: data from the Italian registry for congenital hypothyroidism (1991-1998). J Clin Endocrinol Metab 87 (2002) 557-562
3. De Felice M., and Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25 (2004) 722-746
4. Srivastava D., and Olson E.N. A genetic blueprint for cardiac development. Nature 407 (2000) 221-225
5. Lints T.J., Parsons L.M., Hartley L., Lyons I., and Harvey R.P. Nkx2-5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119 (1993) 419-431
6. Dentice M., Luongo C., Elefante A., Ambrosio R., Salzano S., Zannini M., et al. Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol Cell Biol 25 (2005) 10171-10182
7. Dentice M., Cordeddu V., Rosica A., Ferrara A.M., Santarpia L., Salvatore D., et al. Missense mutation in the transcription factor Nkx2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab 91 (2006) 1428-1433
8. Salvatore D., Bartha T., Harney J.W., and Larsen P.R. Molecular biological and biochemical characterizatio of the human type 2 selenodeiodinase. Endocrinology 137 (1996) 3308-3315
9. Dentice M., Morisco C., Vitale M., Rossi G., Fenzi G., and Salvatore D. The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the dio2 genes to Nkx-2.5 and GATA-4 transcription factors. Molecular Endo 17 (2003) 1508-1521
10. Pachucki J., Hopkins J., Peeters R., Tu H., Carvalho S.D., Kaulbach H., et al. Type 2 idothyronine deiodinase transgene expression in the mouse heart causes cardiac spécifie thyrotoxicosis. Endocrinology 142 (2001) 13-21
11. Trivieri M.G., Oudit G.Y., Sah R., Kerfant B.G., Sun H., Gramolini A.O., et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci USA 103 (2006) 6043-6048
12. Wassen F.W., Schiel A.E., Kuiper G.G., Kaptein E., Bakker O., Visser T.J., et al. Induction of thyroid hormone degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143 (2002) 2812-2815
13. Olivares E.L., Marassi M.P., Fortunato R.S., da Silva A.C., Costa-e-Sousa R.H., Araujo I.G., et al. Thyroid function disturbance and type 3 iodothyronie deiodinase induction after myocardial infarction in rats - a time course study. Endocrinology 148 (2007) 4786-4792
14. Simonides W., Mulcahey M., Redout E., Muller A., Zuidwijk M.G., Visser T.J., et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118 (2008) 975-983
15. Kahaly G.J., and Dillmann W.H. Thyroid hormone action in the heart. Endocr Rev 26 (2005) 704-728
16. Stoykov I., Zandieh-Doulabi B., Moorman A.F.M., Christoffels V., Wiersinga W.M., and Bakker O. Expression pattern and ontogenesis of thyroid hormone receptor isoforms in the mouse heart. J Endocrinol 189 (2006) 231-245
17. Fazio S., Palmieri E.A., Lombardi G., and Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 59 (2004) 31-50
18. Hill J.A., and Olson E.N. Cardiac plasticity. N Engl J Med 358 (2008) 1370-1380
19. Van Rooij E., and Olson E.N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117 (2007) 2369-2376
20. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103 (2006) 18255-18260
21. Van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., and Olson E.N. Control of stress - dependant cardiac growth and gene expression by a microRNA. Science 316 (2007) 575-579
22. Friberg L., Werner S., and Eggertsen G. Rapid down regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?. Arch Intern Med 162 (2002) 1388-1394
23. Ascheim D.D., and Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 12 (2002) 511-515
24. Iervasi G., Pingitore A., Landi P., Raciti M., Ripoli A., Scarlattini M., et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 107 (2003) 708-713
25. Pingitore A., Landi P., Taddei M.C., Ripoli A., L'Abbate A., and Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118 (2005) 132-136
26. Katzeff H.L., Powell S.R., and Ojamaa K. Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3. Am J Physiol 273 (1997) E951-E956
27. Klemperer J.D. Thyroid hormone and cardiac surgery. Thyroid 12 (2002) 517-521
28. Klemperer J.D., Klein J., Gomez M., Helm R.E., Ojamaa K., Thomas S.J., et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333 (1995) 1522-1527
29. Brent G.A., and Hershman J.M. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 63 (1986) 1-8
30. Moruzzi P., Doria E., and Agostoni P.A. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med 101 (1996) 461-467
31. Escobar-Morreale H.F., Del Rey F.E., Obregon M.J., and De Escobar G.M. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinol 137 (1996) 2490-2502
32. Danzi S., Dubon P., and Klein I. Effect of serum T3 on the regulation of cardiac gene expression: role of histone acetylation. Am J Physiol Heart Circ Physiol 289 (2005) 1506-1511
33. Klein I., and Danzi S. Thyroid hormone treatment to mend a broken heart. J Clin Endocrinol Metab 93 (2008) 1172-1174
34. Ojamaa K., Kenessey A., Shenoy R., and Klein I. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol 279 (2000) E1319-E1324
35. Sylven C., Jansson E., Sotonyi P., Waagstein F., Barkhem T., and Bronnegard M. Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Sci 59 (1996) 1917-1922
36. Pingitore A., Galli E., Barison A., Iervasi A., Scarlattini M., Nucci D., et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93 (2008) 1351-1355